PATENT CLAIM ANALYSIS

Application Number: 16364813
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to a method for screening an inhibitor of ATP11C or CDC50A, comprising determining (a) exposure of phosphatidylserine on cell surface, (b) engulfment of cells by macrophages, or (c) cleavage of ATP11C by caspase. The present invention also relates to a method for inducing engulfment of cells by macrophages, comprising inhibiting ATP11C or CDC50A.

Claim (Index 13):
The method according to  claim 11 , which is for screening an agent for the treatment or prophylaxis of a cancer or an apoptosis-related disease.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.86486
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15301762', '14440968', '14394320', '12308542', '15359140']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7084899370336871
- 35 USC 102 Novelty (BERT): 0.6104870994774905
- Combined Prediction Score: 0.6986896532780674
- Mean Citation Score: 271.185914
- Max Citation Score: 649.8838
- Similarity Product: 452.34700177166457

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test